May21135 Innovation in Business- Technology Innovator 2024 | 21 increasing shortage of healthcare workers has caused a decrease in the number of medical interventions and a backlog of surgical procedures, particularly across the US and Western Europe. In the face of such challenges, Life Science Medtech Consultancy leverages the vast experience of its Founder, combined with its expansive network and innovative approach, to successfully traverse the complex landscapes of the Life Sciences and MedTech sectors. It is for this very reason that Life Science Medtech Consultancy has been recognised as the Life Sciences and MedTech Consulting Firm of the Year 2024 – Germany. “As for the upcoming year of 2025 and further onwards,” Stephan concludes, “we will focus on scale-up companies and continue our journey with Made in India, through technology transfer with our local expert partner Tivility. As well as this, we will drive interim management projects to drive sales and company efficiency in privately held and private equity-backed companies.” Contact: Stephan Schliack Company: Life Science Medtech Consulting Web Address: life-science-medtech-consulting.com Life Sciences & MedTech Consulting Firm of the Year 2024 – Germany & Innovation Award for Plant-Based Healthcare Solutions 2024 Based in Berlin, Life Science Medtech Consulting is a specialised consulting firm offering services in the fields of MedTech, commercialisation, and growth through mergers and acquisitions. Renowned for its prowess in valuation and technology adoption analysis, Life Science Medtech Consulting has received recognition in the Technology Innovator Awards 2024. We talk to Stephan Schliack below, Founder of Life Science Medtech Consulting, to learn more about the consultancy’s specialised services. A key market player, Life Science Medtech Consulting provides tailored solutions focused specifically on the Life Sciences and MedTech sectors. The company strives to help its clients achieve their business goals through providing expert valuation and technology adoption analysis, guiding them through effective mergers and acquisitions activities and avoiding mistakes throughout the process. “We offer Life Sciences and MedTech companies the strategic insight, expert guidance, and comprehensive support needed to navigate the complexities in finding the right targets,” says Stephan. “This involves analysing the market opportunity, building the profit and loss, and supporting the commercialisation in Europe. Furthermore, we support geographic expansion, with a focus on India, including manufacturing strategies.” By leveraging this expertise, clients of Life Science Medtech Consulting can achieve their strategic objectives, create value, and foster sustainable growth in the dynamic and highly competitive sectors of Life Sciences and MedTech. With international clients spanning across the US, Finland, Germany, the UK, and India, the company is exposed to the latest trends emerging in the global industry and has a solid network of connections from around the world. Life Science Medtech Consulting strives to respond to the major trends entering the market, with one such example being the 2024 launch of sustainable, plant-based medical technology products in support of decarbonisation and microplastic reduction. Such groundbreaking endeavours has earned the company the Innovation Award for Plant-Based Healthcare Solutions 2024. Additionally, the company has relocated its manufacturing from mainland China to India, and the collaboration with a locally based expert team in India means that Life Science Medtech Consulting can provide its specialised services for small and medium-sized MedTech companies at affordable levels. Since its inception, it has been evident that Life Science Medtech Consulting strives to be on the very forefront of innovation, paying close attention to changes within the industry to ensure that it remains relevant in the dynamic market. Stephan possesses more than 29 years of experience in the MedTech and Life Science industries and has developed an expert understanding of how to best contribute to their development. “The level of innovation must be judged by customers and the provided benefits,” Stephan tells us. “We distinguish between disruption and incremental benefits; the sustainable, plant-based products have been judged as innovation, for example. To deliver on our objective of innovative solutions, we believe in continuously enhancing our listening skills and investing in our professional network.” Stephan tells us that the industry is currently facing various significant challenges, including upcoming tariffs being introduced for manufacturing outside of the US, especially for those based in mainland China. However, this isn’t necessarily a large obstacle for Life Science Medtech Consulting, who can champion these changes with ease due to the opportunities provided by its expansive network and expertise in Central Eastern Europe and India. Additionally, there has been a rise in regulations, such as the Medical Device Regulation, coupled with limited funding for new technologies. This creates compliance and financial hurdles for the industry that must be navigated with care. Finally, the Nov24246
RkJQdWJsaXNoZXIy NTY1MjM3